The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Open accessAbstract
Drug delivery to brain tumors has been a controversial subject. Some believe the blood-brain barrier is not important, while others believe it is the major obstacle in treatment and have devised innovative approaches to circumvent it. These approaches can be divided into two categories: those that attempt to increase drug delivery of intravascularly administered drugs by manipulating either the drugs or capillary permeability, and those that attempt to increase drug delivery by local administration. Several strategies have been developed to increase the fraction of intravascular drug reaching the tumor, including intra-arterial administration, barrier disruption, new ways of packaging drugs, and, most recently, inhibiting drug efflux from tumor. When given intravascularly, all drugs have a common drawback: the body acts as a sink, and, even in the best situations, only a small fraction of administered drug actually reaches the tumor. A consequence is that systemic toxicity is usually the dose-limiting factor. When given locally, such as into the cerebrospinal fluid or directly into the tumor, 100% of an administered dose is delivered to the target site. However, local delivery is associated with variable and unpredictable spatial distribution and variation in drug concentration. The major dose-limiting factor of most local delivery methods will be neurotoxicity. The relative advantages and disadvantages of the different methods of circumventing the blood-brain barrier are presented in this review, and special attention is given to convection-enhanced delivery, which has particular promise for the local delivery of large therapeutic agents such as monoclonal antibodies, antisense oligonucleotides, or viral vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,415
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., et al. (1997) · Nature Medicine · doi:10.1038/nm1297-1354 · Cited by 668
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., Oosten, M. V., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 665
van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 581
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
The next frontier of molecular medicine: Delivery of therapeutics
Jain, R. K. (1998) · Nature Medicine · doi:10.1038/nm0698-655 · Cited by 407
Song, C. X., Labhasetwar, V, Murphy, H., Qu, X., Humphrey, W. R., Shebuski, R. J., & Levy, R. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01484-8 · Cited by 367
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion
Lieberman, D. M., Laske, D. W., Morrison, P. F., Bankiewicz, K. S., & Oldfield, E. H. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.82.6.1021 · Cited by 341
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 328
Blood-Brain Barrier Penetration and in Vivo Activity of an NGF Conjugate
Friden, P. M., Walus, L. R., Watson, P., Doctrow, S. R., Kozarich, J. W., Bäckman, C., Bergman, H., Hoffer, B., Bloom, F., & Granholm, A.-C. (1993) · Science · doi:10.1126/science.8420006 · Cited by 325
Pardridge, W. M., Kang, Y.-S., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 315
High-flow microinfusion: tissue penetration and pharmacodynamics
Morrison, P. F., Laske, D. W., Bobo, H., Oldfield, E. H., & Dedrick, R. L. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.1.r292 · Cited by 313
Delivery of Molecular Medicine to Solid Tumors
Jain, R. K. (1996) · Science · doi:10.1126/science.271.5252.1079 · Cited by 312
Schlageter, K. E., Molnar, P., Lapin, G. D., & Groothuis, D. R. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2188 · Cited by 293
Self-citationFung, L. K., Ewend, M. G., Sills, A. K., Sipos, E. P., Thompson, R. C., Watts, M., Colvin, O. M., Brem, H., & Saltzman, W. M. (1998) · PubMed · Cited by 289
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
de Lange, E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00014-3 · Cited by 226
Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion
Patlak, C., & Fenstermacher, J. (1975) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1975.229.4.877 · Cited by 206
Chemotherapy of Brain Tumors: The "Blood-Brain Barrier" Is Not a Factor
Vick, N. A. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500210025002 · Cited by 195
Bigner, D. D., Brown, M. T., Friedman, A. H., Coleman, R. E., Akabani, G., Friedman, H. S., Thorstad, W. L., McLendon, R. E., Bigner, S. H., Zhao, X. G., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2202 · Cited by 192
A critical evaluation of the principles governing the advantages of intra-arterial infusions
Eckman, W. W., Patlak, C. S., & Fenstermacher, J. D. (1974) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059765 · Cited by 183
Hendrikse, N. H., Schinkel, A. H., De Vries, E. G. E., Fluks, E., Van der Graaf, W. T. A., Willemsen, A. T. M., Vaalburg, W., & Franssen, E. J. F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701979 · Cited by 182
Cao, X., & Shoichet, M. S. (1999) · Biomaterials · doi:10.1016/s0142-9612(98)00172-0 · Cited by 178
Neuwelt, E. A., Frenkel, E. P., Diehl, J., Vu, L. H., Rapoport, S., & Hill, S. (1980) · Neurosurgery · doi:10.1227/00006123-198007000-00007 · Cited by 163
Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain Tumors
Inamura, T., & Black, K. L. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.108 · Cited by 160
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
Bickel, U., Yoshikawa, T., Landaw, E. M., Faull, K. F., & Pardridge, W. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2618 · Cited by 157
Ghersi‐Egea, J., Finnegan, W., Chen, J.-L., & Fenstermacher, J. D. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00281-3 · Cited by 157
Laske, D. W., Morrison, P. F., Lieberman, D. M., Corthesy, M. E., Reynolds, J. C., Stewart-Henney, P. A., Koong, S.-S., Cummins, A. C., Paik, C. H., & Oldfield, E. H. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.87.4.0586 · Cited by 144
Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7
Sanovich, E. Y., Bartus, R. T., Friden, P. M., Dean, R. L., Le, H. Q., & Brightman, M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01143-9 · Cited by 142
Quantitative Examination of Tissue Concentration Profiles Associated with Microdialysis
Dykstra, K. H., Hsiao, J., Morrison, P. F., Bungay, P. M., Mefford, I. N., Scully, M. M., & Dedrick, R. L. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09346.x · Cited by 141
Do anticancer agents reach the tumor target in the human brain?
Donelli, M. G., Zucchetti, M., & D’Incalci, M. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686291 · Cited by 139
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors
Stewart, D. J. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052723 · Cited by 131
Quantitative approaches to in vivo brain microdialysis.
Parsons, L. H., & Justice, J. B. (1994) · PubMed · Cited by 127
Therapeutic opportunities for targeted liposomal drug delivery
Allen, T. M., & Moase, E. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00402-4 · Cited by 126
Osmotic Opening of the Blood-Brain Barrier in the Monkey without Associated Neurological Deficits
Rapoport, S. I., & Thompson, H. K. (1973) · Science · doi:10.1126/science.180.4089.971 · Cited by 120
Quantification and pharmacokinetics of blood-brain barrier disruption in humans
Zünkeler, B., Carson, R. E., Olson, J., Blasberg, R. G., DeVroom, H. L., Lutz, R. J., Saris, S. C., Wright, D. C., Kammerer, W. A., Patronas, N. J., et al. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.85.6.1056 · Cited by 111
Rg, B., Cs, P., & Wr, S. (1977) · PubMed · Cited by 110
Blood-brain barrier function of P-glycoprotein
Tsuji, A., & Tamai, I. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00504-8 · Cited by 108
Quantitative assessment of blood-brain barrier damage during microdialysis.
Morgan, M. E., Singhal, D., & Anderson, B. D. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12905-4 · Cited by 106
Drug delivery through the blood-brain barrier
Tamai, I., & Tsuji, A. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00011-7 · Cited by 101
The entry of antiviral and antiretroviral drugs into the central nervous system
Groothuis, D. R., & Levy, R. M. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709031185 · Cited by 101
Self-citationNeuwelt, E. A., Balaban, E. P., Diehl, J., Hill, S. A., & Frenkel, E. P. (1983) · Neurosurgery · doi:10.1227/00006123-198306000-00013 · Cited by 97
Chemotherapy of brain tumors: physiological and pharmacokinetic considerations.
Blasberg, R. G., & Groothuis, D. R. (1986) · PubMed · Cited by 95
Self-citationGroothuis, D. R., Ward, S., Schlageter, K. E., Itskovich, A. C., Schwerin, S. C., Allen, C. V., Dills, C. V., & Levy, R. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00572-1 · Cited by 95
Self-citationGroothuis, D. R., Ward, S., Itskovich, A. C., Dobrescu, C., Allen, C. V., Dills, C. V., & Levy, R. M. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.90.2.0321 · Cited by 95
Self-citationBlack, K. L., Cloughesy, T. F., Huang, S., Gobin, Y. P., Zhou, Y., Grous, J. J., Nelson, G., Farahani, K., Hoh, C. K., & Phelps, M. E. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.4.0603 · Cited by 93
Intracerebral Dialysis and the Blood‐Brain Barrier
Westergren, I., Nyström, B., Hamberger, A., & Johansson, B. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010229.x · Cited by 83
Microdialysis for pharmacokinetic analysis of drug transport to the brain
de Lange, E. C. M., de Boer, B. G., & Breimer, D. D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00089-1 · Cited by 81
Peptides and blood-brain barrier transport
Ermisch, A., Brust, P., Kretzschmar, R., & Rühle, H. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.3.489 · Cited by 81
Tamai, I., Sai, Y., Kobayashi, H., Kamata, M., Wakamiya, T., & Tsuji, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36406-7 · Cited by 80
Interstitial chemotherapy for brain tumors: review
Tomita, T. (1991) · Journal of Neuro-Oncology · doi:10.1007/bf00151247 · Cited by 78
Blasberg, R. G., Nakagawa, H., Bourdon, M. A., Groothuis, D. R., Patlak, C. S., & Bigner, D. D. (1987) · PubMed · Cited by 72
Self-citationFärkkilä, M. A., Jääskeläinen, J. E., Kallio, M., Blomstedt, G. C., Raininko, R., Virkkunen, P. J., Paetau, A. E., SARELIN, H., & Mäntylä, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.263 · Cited by 70
Boado, R. J., Tsukamoto, H., & Pardridge, W. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9800836 · Cited by 69
Biochemical opening of the blood-brain barrier
Black, K. L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00004-q · Cited by 69
Hsiao, M., Tse, V., Carmel, J. B., Tsai, Y.-L., Felgner, P. L., Haas, M., & Silverberg, G. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6459 · Cited by 63
Devineni, D., Klein–Szanto, A. J., & Gallo, J. M. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050518 · Cited by 56
Vector-mediated peptide drug delivery to the brain
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00007-t · Cited by 55
Ford, J., Osborn, C., Barton, T., & Bleehen, N. M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00155-5 · Cited by 55
von Bossanyi, P., Diete, S., Dietzmann, K., Warich-Kirches, M., & Kirches, E. (1997) · Acta Neuropathologica · doi:10.1007/s004010050756 · Cited by 53
Modulation of Blood-Brain Barrier Permeability
Rapoport, S. I. (1996) · Journal of drug targeting · doi:10.3109/10611869609015962 · Cited by 53
Blood-Brain Barrier Disruption in the Treatment of Brain Tumors: Clinical Implications
Neuwelt, E. A., & Dahlborg, S. A. (1989) · Springer eBooks · doi:10.1007/978-1-4615-7255-8_5 · Cited by 50
A novel chemical delivery system for brain targeting
Yoshikawa, T., Sakaeda, T., Sugawara, T., Hirano, K., & Stella, V. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00091-x · Cited by 40
Friden, P. M., Olson, T. S., Obar, R. A., Walus, L. R., & Putney, S. D. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20804-7 · Cited by 39
Liposome targeting to rat brain: effect of osmotic opening of the blood-brain barrier
Sakamoto, A., & Ido, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)90499-d · Cited by 36
The blood-brain barrier as a target for pharmacological modulation.
Bartus, R. T. (1999) · PubMed · Cited by 35
Multidrug Resistance in Glioblastoma
Leweke, F., Damian, M. S., Schindler, C., & Schachenmayr, W. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80015-0 · Cited by 34
Increased opening of blood-tumour barrier by leukotriene C4is dependent on size of molecules
Black, K. L., & Chio, C. (1992) · Neurological Research · doi:10.1080/01616412.1992.11740093 · Cited by 31
Gutman, M., Laufer, R., Eisenthal, A., Goldman, G., Ravid, A., Inbar, M., & Klausner, J. M. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050328 · Cited by 24
Olivi, A., & Brem, H. (1994) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-85039-4_15 · Cited by 19
Sdiqui, N., & Akhtar, S. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00363-3 · Cited by 10
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Metadata
- Authors
- Groothuis, D. R.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01-01
- Volume
- 2
- Issue
- 1
- Pages
- 45-59
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2117553516
- Cited by
- 456
- References
- 75
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.